Sep 16, 2024 7:30am EDT Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024
Sep 4, 2024 8:00am EDT Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference